NLRP2在脑缺血损伤中的作用及机制
[Abstract]:In recent years, cerebral apoplexy is the main cause of long-term disability and death in the world, characterized by high morbidity, high mortality, high disability and high recurrence rate. Among them, ischemic stroke is more common than hemorrhagic stroke, with a proportion of more than 80%, which is due to obstruction of the brain artery to block the flow of blood to the brain. The pathophysiological process of ischemic cerebral apoplexy is complex and extensive, including oxidative stress, toxic effects of excitatory amino acids, energy metabolism disorders, changes in dynamic balance of cell ions, increased intracellular calcium levels, active oxygen mediated toxicity, and cytotoxic effects mediated by inflammatory cytokines. Recent studies have shown that the inflammatory response of the innate immune system is closely related to the process and progress of cerebral ischemia. The innate immune system is the first line of defense to restrict the undamaged host, and the intracellular and extracellular domain of the pattern recognition receptor (PRRs) can detect acute damage and initiate the inflammatory reaction. The oligomeric domain (NOD) - like receptor (NLRs) is a member of the intracellular pattern recognition receptor family and plays a key role in the inflammatory response. In the 22 category of human NLRs, 14 types include the thermal protein domain and form a NLRP subtype (NLRPs). In the NLRPs family, some members, such as NLRP1, NLRP3, and NLRP6, have been deeply studied, and they are available The recruitment of pro-caspase-1 through binding protein ASC activates the inflammatory corpuscles and activates the inactive pro-caspase-1 to mature caspase-1, resulting in the production and release of IL-1 beta and IL-18 and triggering the inflammatory reaction. And the role is rarely studied, especially in the central nervous system. Then whether NLRP2 is expressed in the central nervous system in the body and whether it is associated with cerebral ischemia, such as cerebral ischemia, is still needed to be further explored. In this experimental study, the model of the middle cerebral artery embolism (MCAO) and the glucose deprivation (OGD) model of the cultured cells were established. To explore the role and possible mechanism of NLRP2 in cerebral ischemia from two aspects in vivo and in vitro. Method 1 NLRP2 expression changes after cerebral ischemia in mice and the construction of cerebral ischemia model in 1.1 C57BL/6 wild type mice and neurology score 1.1.1 selected mice and construct ischemic model to select male wild type C57BL/6 experimental mice, weight 23g left Right, establish a middle cerebral artery embolism model. Neck median incision, incision of skin, separation of the left common carotid artery, internal carotid artery and external carotid artery under the microscope. The nylon thread plug is carefully inserted into the common carotid artery. When the cerebral blood flow meter detects the sudden drop of blood flow, it stops continuously and starts the time, after 12,24,48 hours, the mice are killed and taken to take mice fetch. Material.1.1.2 was used to evaluate the expression of NLRP2 in the brain of.1.2 after cerebral ischemia and its distribution and distribution of 1.2.1 using protein immunoblotting (Western blot, WB), Real-time PCR and immunohistochemistry (immunohistochemistry, IHC) for the detection of the changes in the expression of NLRP2 in the brain after cerebral ischemia. Immunofluorescence (IF) method for the detection of NLRP2 and the marker proteins of different cells in the brain of the mice, the distribution of NLRP2 in the brain, the construction of the.1.3 in vitro model and the detection of the original astrocytes by NLRP2 in vitro, and the establishment of oxygen deprivation (Oxygen Glucose Deprivation, OGD) model, respectively, for OGD. Treatment of 0.5,1,1.5,2h, Western blot (WB), tissue immunofluorescence (immunofluorescence, IF) and Real-time PCR detection of the expression of NLRP2 in the primary astrocytes after OGD;.2 NLRP2 in the brain ischemia injury in mice 2.1 injection of adeno-associated virus in mouse brain to use brain stereotaxis Injection of adeno-related virus vectors carrying NLRP2 silencing gene into specific parts of the nervous system by injection technique, the NLRP2 gene.2.2 injected into this site is injected into the brain of mice and the mice with NLRP2 silencing genes are injected into the brain. The brain of mice injected with NLRP2 silencing gene was stained with TTC, and the morphological damage was evaluated in.2.3 mice model of cerebral ischemia. CBA, Real-time PCR method was used to detect the level of pro-inflammatory factors in the brain homogenate of mice with NLRP2 silencing basis and.2. The effect of.4 NLRP2 on the apoptosis of primary astrocytes induced by OGD 2.4.1 the apoptosis of astrocytes transfected with 2.4.2 astrocytes, OGD treatment of astrocytes transfected with si-NLRP2, and the effect of Annexin V/PI staining on the apoptosis of primary astrocytes using flow cytometry to detect the apoptosis of astrocytes The regulation of NLRP2 pathway in.3 cerebral ischemia injury WB detection of NLRP2 effect on the level of Caspase-1, ASC, IL-1 beta in the brain of mice after cerebral ischemia The effect of NLRP2 on the expression of Caspase-1, p-p65, IL-1 beta in si-NLRP2 astrocytes after OGD treatment. Results 1 the expression of NLRP2 and its downstream molecules in the brain after cerebral ischemia in mice and the construction of the 1.1 C57BL/6 mouse model of cerebral ischemia and the neurology score were less than 2 in each group due to death or neurology score. The expression of NLRP2 in the brain of mice after.1.2 cerebral ischemia was removed and the distribution of NLRP2 in the brain of mice was removed and the distribution of 1.2.1 using protein immunoblotting (Western blot, WB), Real-time PCR and immunohistochemistry (immunohistochemistry, IHC) were used to detect the changes of NLRP2 expression after cerebral ischemia. We found that after cerebral ischemia, we found that the NLRP2 was after cerebral ischemia. The expression rose obviously and reached the peak in 24 hours. The results of immunohistochemical staining showed that.1.2.2 was mainly expressed in the primary astrocytes by immunofluorescence staining, and that NLRP2 was also expressed in the neurons. In the microglia, there was little expression of the expression of.1.3 in vitro model and the detection of NLRP2 in vitro. On behalf of astrocytes, the OGD model of oxygen deprivation was established. Through the analysis of WB and Real-time PCR, we found that the expression of NLRP2 increased significantly after OGD and reached the peak in OGD1.5 hours. The results of immunofluorescence showed that after the cell OGD1.5 hours, the expression of NLRP2 expression increased.2 NLRP2 in the cerebral ischemia injury of mice 2.1 injection of adeno-associated virus silencing. 4 weeks after the NLRP2 gene injection of the virus in the brain of mice, OCT was embedded in the brain tissue of mice. The scope of the virus infection was observed under the microscope under the microscope. The scope of the virus infection was larger, covering the.2.2 injection of the middle cerebral artery and the.2.2 virus with the NLRP2 silencing gene. After NLRP2 silencing gene cerebral ischemia, the neurology score of mice decreased obviously and the area of cerebral infarction decreased obviously. The detection of inflammatory factors in the.2.3 mice model of cerebral ischemia had cerebral ischemia treatment on mice injected with the virus and the virus injected with the NLRP2 silencing gene. The results of CBA and Real-time PCR showed the decline of NLRP2 expression caused by the injection virus. The effects of IL-1 beta, IL-18, IL-6, TNF- alpha MCP-1 and other inflammatory factors on the apoptosis of primary astrocytes induced by OGD can be alleviated by the flow cytometry results showed that the astrocytes transfected with si-NLRP2 were treated with OGD, and apoptotic astrocytes significantly reduced NLRP2 pathways in.3 cerebral ischemia. The WB results showed that the expression of NLRP2, caspase-1, ASC, IL-1 beta and other related proteins increased after cerebral ischemia in mice, and the mice injected with NLRP2 silencing genes decreased the NLRP2 expression compared with the mice injected with the empty virus, and the decrease of NLRP2 caused by the mice injected with the NLRP2 silent gene could reduce the cerebral ischemia. The associated proteins such as caspase-1, ASC, IL-1 beta and other related proteins were raised, and primary astrocytes were cultured. WB results showed that the expression of NLRP2 in siRNA-NLRP2 astrocytes decreased significantly. The decrease of NLRP2 expression caused by transfection of siRNA-NLRP2 cells could reduce caspase-1, p-p65, IL-I beta and other related proteins caused by OGD. This experiment is the first time to demonstrate the expression of NLRP2 in cerebral ischemia injury. It is found that the expression of NLRP2 increases after cerebral ischemia injury, which leads to the increase of Caspase-1, ASC, IL-1 beta and other related proteins, and the loss of NLRP2 can reduce the area of cerebral infarction and improve the cerebral ischemia injury, which has some preventive effect on cerebral ischemia.
【学位授予单位】:山东大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R743
【相似文献】
相关期刊论文 前10条
1 李杰;胡跃强;董少龙;;内源性神经干细胞治疗脑缺血损伤的研究进展[J];广西中医学院学报;2009年04期
2 田彩云;杨玉梅;;神经元特异性烯醇化酶在脑缺血损伤中的意义[J];包头医学院学报;2013年04期
3 刘 萍;钙与脑缺血损伤[J];国外医学.神经病学神经外科学分册;2002年03期
4 王旭辉,李世亭;胶质细胞源性神经营养因子与脑缺血损伤[J];卒中与神经疾病;2004年04期
5 陈伟;张敬军;;干细胞对脑缺血损伤的潜在性治疗作用[J];中国微循环;2006年04期
6 李宁;李建生;刘敬霞;;骨髓间充质干细胞移植治疗脑缺血损伤及中医药对其影响的研究进展[J];辽宁中医杂志;2007年06期
7 李建生;刘敬霞;;老年脑缺血损伤及治疗策略的思考[J];中国老年学杂志;2007年15期
8 应诗达;脑缺血损伤复苏的进展[J];中国急救医学;1995年06期
9 赵人瑞;脑缺血损伤的新概念及治疗时机[J];西藏医药杂志;1998年03期
10 杨冀萍;刘怀军;;丝裂原活化蛋白激酶在脑缺血损伤中的作用及其调控机制[J];中国临床康复;2006年10期
相关会议论文 前10条
1 李建生;刘敬霞;;老年脑缺血损伤及治疗策略的思考[A];第五次全国中西医结合养生学与康复医学学术研讨会论文集[C];2006年
2 刘敬霞;李建生;;老年脑缺血损伤后神经细胞反应的研究进展[A];中华中医药学会老年神经病专题学术研讨会论文专辑[C];2006年
3 赵清;杜怡峰;;脑缺血损伤与炎性因子的研究进展[A];山东省第三次中西医结合神经内科学术研讨会论文汇编[C];2011年
4 王晔;邓宇斌;胡贞贞;王亚柱;;静脉注射骨髓间充质干细胞定向迁移至脑缺血损伤部位的分子机制研究[A];第11次中国实验血液学会议论文汇编[C];2007年
5 郑庆平;胡永善;白玉龙;孙莉敏;贾杰;朱大年;崔晓;;康复训练对脑缺血损伤血管生成素的影响[A];中华医学会第九次全国物理医学与康复学学术会议论文集[C];2007年
6 李建生;刘敬霞;张伟宇;梁生旺;王冬;方建;;大黄素抗大鼠脑缺血损伤及对炎性因子反应的影响[A];2005全国中医脑病学术研讨会论文汇编[C];2005年
7 李建生;刘敬霞;张伟宇;梁生旺;王冬;方建;;大黄素抗大鼠脑缺血损伤及对炎性因子反应的影响(摘要)[A];第八次全国中西医结合虚证与老年医学学术研讨会论文集[C];2005年
8 潘家祜;刘实晶;谢德龙;;GBE50对大鼠局脑缺血损伤的预防作用[A];第五次全国中西医结合血瘀证及活血化瘀研究学术大会论文汇编[C];2001年
9 关健;戴建武;佟伟民;朱朝辉;杜世伟;吴晨希;王任直;;脑源性神经营养因子对大鼠脑缺血损伤的治疗作用[A];2011中华医学会神经外科学学术会议论文汇编[C];2011年
10 陈文明;钱民章;;MCPIP在脑缺血损伤中的表达[A];生命的分子机器及其调控网络——2012年全国生物化学与分子生物学学术大会摘要集[C];2012年
相关重要报纸文章 前2条
1 蒋明;我学者发现当归治疗脑缺血损伤机制[N];科技日报;2004年
2 陶春祥;脑缺血损伤再灌注的中药研究[N];中国医药报;2003年
相关博士学位论文 前10条
1 张宇玲;早期运动训练对脑缺血损伤大鼠的脑保护作用及其机制研究[D];复旦大学;2014年
2 刘蔚;埃他卡林对脑缺血损伤的保护作用及其药理学特征的研究[D];中国人民解放军军事医学科学院;2005年
3 富苏;通络化痰胶囊对脑缺血损伤的保护作用及机制研究[D];北京中医药大学;2013年
4 高丽;血管紧张素-(1-7)在高血压及脑缺血损伤中的作用及机制研究[D];南京医科大学;2013年
5 尹勇;运动再学习疗法对猴脑缺血损伤功能恢复的影响[D];昆明医科大学;2013年
6 陈亮;参与脑缺血损伤和保护机制的蛋白靶点筛查[D];第一军医大学;2007年
7 何昆燕;剪切修复偶联因子1(ERCC1)在大鼠脑缺血损伤病理过程中的作用研究[D];复旦大学;2006年
8 刘芳;脑健片对脑缺血损伤的干预及其主要药效成分的药代动力学研究[D];湖南中医药大学;2014年
9 邓姣;代谢障碍小鼠脑血管结构及脑缺血损伤的变化与防治措施研究[D];第四军医大学;2013年
10 钟海星;TAT-LBD-Ngn2对脑缺血损伤的保护作用及其机制研究[D];第四军医大学;2013年
相关硕士学位论文 前10条
1 屈代鑫;脑缺血大鼠脑组织和血浆的蛋白组学分析及STVNa对脑缺血损伤的调节作用[D];华南理工大学;2015年
2 冯翔;阿尔茨海默症小鼠对脑缺血损伤易感性的研究[D];兰州大学;2014年
3 沈遥遥;阿托伐他汀预处理对局灶性脑缺血损伤中星形胶质细胞缝隙连接通讯的作用[D];南昌大学;2016年
4 宋晓;NLRP2在脑缺血损伤中的作用及机制[D];山东大学;2017年
5 王承;蒺藜皂苷对急性不完全脑缺血损伤的保护作用[D];吉林大学;2009年
6 刘如练;细胞膜保护剂与活血化瘀药配伍抗脑缺血损伤的研究[D];成都中医药大学;2009年
7 杨海;睾丸酮对小鼠脑缺血损伤后神经元和星形胶质细胞凋亡影响的实验研究[D];新疆医科大学;2005年
8 季红超;全脑缺血损伤大鼠海马CA1区神经细胞死亡方式的实验研究[D];辽宁医学院;2013年
9 谢彬;三种藏药联合给药对大鼠脑缺血损伤的药效作用研究[D];西南交通大学;2014年
10 刘佳;重组HPPCn蛋白的制备及其在脑缺血损伤中的作用初探[D];天津大学;2009年
,本文编号:2152292
本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/2152292.html